ACETAZOLAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Acetazolamide patents expire, and what generic alternatives are available?
Acetazolamide is a drug marketed by Accord Hlthcare, Alembic, Cadila, Heritage Pharma, Indicus Pharma, Micro Labs Ltd India, Nostrum Labs Inc, Novast Labs, Rising, Ajanta Pharma Ltd, Alra, Appco, Ascot, Breckenridge, Chartwell Molecular, Eywa Pharma, Mankind Pharma, Ne Rx Pharma, Novitium Pharma, Rubicon, Strides Pharma, Sun Pharm Industries, Taro, Torrent, Vangard, Watson Labs, Zydus, Avet Lifesciences, Hikma, Hospira, Mylan Asi, Par Sterile Products, Xgen Pharms, and Zydus Pharms. and is included in thirty-six NDAs.
The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetazolamide
A generic version of ACETAZOLAMIDE was approved as acetazolamide sodium by HIKMA on February 28th, 1995.
Summary for ACETAZOLAMIDE
US Patents: | 0 |
Applicants: | 34 |
NDAs: | 36 |
Finished Product Suppliers / Packagers: | 32 |
Raw Ingredient (Bulk) Api Vendors: | 125 |
Clinical Trials: | 139 |
Patent Applications: | 5,016 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ACETAZOLAMIDE |
DailyMed Link: | ACETAZOLAMIDE at DailyMed |
Recent Clinical Trials for ACETAZOLAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Incannex Healthcare Ltd | Phase 1 |
Rambam Health Care Campus | Phase 4 |
National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
Pharmacology for ACETAZOLAMIDE
Drug Class | Carbonic Anhydrase Inhibitor |
Mechanism of Action | Carbonic Anhydrase Inhibitors |
Medical Subject Heading (MeSH) Categories for ACETAZOLAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for ACETAZOLAMIDE
US Patents and Regulatory Information for ACETAZOLAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 084498-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Strides Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 209734-001 | Nov 20, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Xgen Pharms | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 040784-001 | Dec 10, 2008 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |